Filed: 10/10/2023ACC: 0001979460-23-000008
📋 What this filing means
GILFOYLE MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $24.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$24.2K
Total AUM (reported)
335.00
Total Shares
Allocation by class
COMMON STOCK$10.3K42.5%
INNOVATION ETF$5.9K24.4%
CORE SP 500 ETF$4.3K18.0%
UNIT SERIES 1$3.7K15.2%
Portfolio Concentration
Top 3$16.6K68.7%
4–10$7.6K31.3%
Top 3 weight
68.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 335.00
Sole
Full voting authority
335.00
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
CRISPR THERAPEUTICS AG
SOLEShares150.00
TypeSH
Market value$6.4K
26.37%
Sole
150.00
Shared
0.00
None
0.00
ARK ETF TRUST
SOLEShares150.00
TypeSH
Market value$5.9K
24.41%
Sole
150.00
Shared
0.00
None
0.00
ISHARES INC
SOLEShares10.00
TypeSH
Market value$4.3K
17.95%
Sole
10.00
Shared
0.00
None
0.00
TESLA INC
SOLEShares15.00
TypeSH
Market value$3.9K
16.11%
Sole
15.00
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares10.00
TypeSH
Market value$3.7K
15.16%
Sole
10.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR THERAPEUTICS AGSOLE | COMMON STOCK | 150.00 | SH | $6.4K 26.37% | 150.00 | 0.00 | 0.00 |
ARK ETF TRUSTSOLE | INNOVATION ETF | 150.00 | SH | $5.9K 24.41% | 150.00 | 0.00 | 0.00 |
ISHARES INCSOLE | CORE SP 500 ETF | 10.00 | SH | $4.3K 17.95% | 10.00 | 0.00 | 0.00 |
TESLA INCSOLE | COMMON STOCK | 15.00 | SH | $3.9K 16.11% | 15.00 | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SERIES 1 | 10.00 | SH | $3.7K 15.16% | 10.00 | 0.00 | 0.00 |